Overcoming the bottlenecks in financing young biotech companies PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Overcoming the bottlenecks in financing young biotech companies PDF full book. Access full book title Overcoming the bottlenecks in financing young biotech companies by Sascha Berger. Download full books in PDF and EPUB format.
Author: Sascha Berger
Publisher: GRIN Verlag
ISBN: 3638054721
Category : Business & Economics
Languages : en
Pages : 80
Get Book
Book Description
Diploma Thesis from the year 2007 in the subject Business economics - Investment and Finance, grade: 1,3, Technical University of Munich (KfW Stiftungslehrstuhl für Entrepreneurial Finance), language: English, abstract: In this book the question of how to overcome specific bottlenecks in financing young biotech companies was posed. The answer is manifold and includes the the usage of the multitude of financial options. Hence, first, the unique characteristics of the industry were described and specific financial bottlenecks were revealed. The eminence of a major bottleneck, typically in the seed-phase of a biotech venture, was taken as reason for further elaborations. I based these elaborations primarily upon an analysis of interviews. Several qualitative and predominantly personal interviews were conducted in the Munich biotech cluster, covering three decisive groups of respondents: biotech executives and founders, venture capital investors and external industry experts. The obtained extensive experiences were finally collected, clustered and compared. My key finding was that this bottleneck is mainly rooted in the fact that, when a young biotech firm leaves the academia, a big money provider (a Venture Capitalist or corporate partner) is often not yet willing to invest. A technological proof-of-concept is demanded by the latter, which is, however, not yet sufficiently provided by the former. Cluster structures might generally be helpful, but do not change this fundamental logic either. Based on this analysis, and taking into account the many other revealed points to improve, I came up with an exhaustive roadmap how to tackle the bottlenecks, covering all major endogenous and exogenous factors. This list of suggestions was supplemented with some basic thoughts on biotech finance strategies as also lastly a description of a comprehensive biotech finance cycle.
Author: Sascha Berger
Publisher: GRIN Verlag
ISBN: 3638054721
Category : Business & Economics
Languages : en
Pages : 80
Get Book
Book Description
Diploma Thesis from the year 2007 in the subject Business economics - Investment and Finance, grade: 1,3, Technical University of Munich (KfW Stiftungslehrstuhl für Entrepreneurial Finance), language: English, abstract: In this book the question of how to overcome specific bottlenecks in financing young biotech companies was posed. The answer is manifold and includes the the usage of the multitude of financial options. Hence, first, the unique characteristics of the industry were described and specific financial bottlenecks were revealed. The eminence of a major bottleneck, typically in the seed-phase of a biotech venture, was taken as reason for further elaborations. I based these elaborations primarily upon an analysis of interviews. Several qualitative and predominantly personal interviews were conducted in the Munich biotech cluster, covering three decisive groups of respondents: biotech executives and founders, venture capital investors and external industry experts. The obtained extensive experiences were finally collected, clustered and compared. My key finding was that this bottleneck is mainly rooted in the fact that, when a young biotech firm leaves the academia, a big money provider (a Venture Capitalist or corporate partner) is often not yet willing to invest. A technological proof-of-concept is demanded by the latter, which is, however, not yet sufficiently provided by the former. Cluster structures might generally be helpful, but do not change this fundamental logic either. Based on this analysis, and taking into account the many other revealed points to improve, I came up with an exhaustive roadmap how to tackle the bottlenecks, covering all major endogenous and exogenous factors. This list of suggestions was supplemented with some basic thoughts on biotech finance strategies as also lastly a description of a comprehensive biotech finance cycle.
Author: Jeffrey J. Reuer
Publisher: Oxford University Press
ISBN: 0190683678
Category : Business & Economics
Languages : en
Pages : 752
Get Book
Book Description
Organizational collaboration has played an important role in the field of strategic management in recent decades, including influential works on joint ventures, networks, and social capital. Likewise, the field of entrepreneurship has long recognized the value of collaboration, since young ventures often don't have the latitude to own or control all of the resources they need. Rather, the conditions of uncertainty and resource scarcity inherent in entrepreneurship push these ventures to creatively access resources, often through partnerships and collaborations that vary in formality. Though the importance of collaboration to entrepreneurship might seem apparent, research on it is distributed across multiple contexts, theoretical perspectives, and units of analysis. The Oxford Handbook of Entrepreneurship and Collaboration is a comprehensive volume that addresses the most important topics related to collaboration and connects them to unique challenges and opportunities related to entrepreneurship. Bringing together leading scholars from both areas, the volume takes stock of the current literature and aims to advance this body of research by highlighting the role that collaboration plays in value creation, resource acquisition, and the development of entrepreneurial ventures.
Author: Daham I. Alani
Publisher: Springer Science & Business Media
ISBN: 9400943210
Category : Science
Languages : en
Pages : 376
Get Book
Book Description
Upon an invitation from Arab Bureau of Education for the Gulf States "ABEGS"; an International Conference on Biotechnology and Applied Microbiol ogy was held in Riyadh, Saudi Arabia, 12-15 November 1984. The Conference was sponsored by ABEGS and organized through coopera tion with Saudi Biological Society "SBS". ABEGS was established in 1976 with the aim of coordinating, unifying and developing all aspects of Education, Culture and Science in the Gulf States. In the field of publications, ABEGS is publishing various books, pamphlets and two scientific journals, one in Arabic and the other in English entitled: the Arab Gulf Journal of Scientific Research. This volume contains topics presented by the invited speakers and selected papers from among those submitted by participants. Selection was done on basis of some of the invited talks. Main topics of the conference were grouped into sections representing seven themes of Biotechnology and Applied Microbiology: - production of microbial proteins - utilization of microorganisms for the production of chemicals - microbial treatment and utilization of waste - continuous culture - application of biotechnology in plant science - applied microbiology and environment and - applied microbiology and biotechnology: international cooperation - tween developed and developing countries. Some of the topics in this volume present surveys of recent developments in several important areas of biotechnology and applied microbiology, while the remaining papers carry detailed research contributions.
Author: European Investment Bank
Publisher: European Investment Bank
ISBN: 9286144679
Category : Business & Economics
Languages : en
Pages : 634
Get Book
Book Description
The Investment Report, issued annually by the European Investment Bank, provides a comprehensive overview and analysis of investment and the financing of investment in the European Union. It combines the exploration of investment trends with in-depth analysis, focusing especially on the drivers and barriers to investment activity. The report leverages on a unique set of databases and survey data, including EIBIS, an annual survey of 13 500 firms in Europe, which focuses on their assessment of investment and investment finance conditions, and which allows analysis with firm balance sheet information. The report provides critical inputs to policy debates on the need for public action on investment, and on the types of intervention that can have the greatest impact.
Author:
Publisher: Ministry of Economics
ISBN: 9985987578
Category :
Languages : en
Pages : 132
Get Book
Book Description
Author: Alfredo Pereira Jr
Publisher: Springer Nature
ISBN: 3031400259
Category : Business & Economics
Languages : en
Pages : 250
Get Book
Book Description
This edited volume provides strategies for reducing inequality and promoting human development through the use of innovative digital technology and the adoption of new bioethical principles for governance. The book is structured around a series of practical proposals which can be adapted to different circumstances, countries, and political systems. Written by an interdisciplinary panel of international researchers and professionals, each chapter details a proposal for a policy—new social technology, Green Deals, robust social assistance—that will move society forward towards a sustainable, digital, and equitable future. Researchers across multiple disciplines--public administration, cognitive technology, E-learning, finance, philosophy of economy, agronomics, forest engineering, bioethics and education—will find this volume a useful reference.
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309292492
Category : Medical
Languages : en
Pages : 107
Get Book
Book Description
Improving and Accelerating Therapeutic Development for Nervous System Disorders is the summary of a workshop convened by the IOM Forum on Neuroscience and Nervous System Disorders to examine opportunities to accelerate early phases of drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials, explored how new and emerging tools and technologies may improve the efficiency of research, and considered mechanisms to facilitate a more effective and efficient development pipeline. There are several challenges to the current drug development pipeline for nervous system disorders. The fundamental etiology and pathophysiology of many nervous system disorders are unknown and the brain is inaccessible to study, making it difficult to develop accurate models. Patient heterogeneity is high, disease pathology can occur years to decades before becoming clinically apparent, and diagnostic and treatment biomarkers are lacking. In addition, the lack of validated targets, limitations related to the predictive validity of animal models - the extent to which the model predicts clinical efficacy - and regulatory barriers can also impede translation and drug development for nervous system disorders. Improving and Accelerating Therapeutic Development for Nervous System Disorders identifies avenues for moving directly from cellular models to human trials, minimizing the need for animal models to test efficacy, and discusses the potential benefits and risks of such an approach. This report is a timely discussion of opportunities to improve early drug development with a focus toward preclinical trials.
Author: International Monetary Fund. European Dept.
Publisher: International Monetary Fund
ISBN: 1484341368
Category : Business & Economics
Languages : en
Pages : 97
Get Book
Book Description
This 2017 Article IV Consultation highlights the macroeconomic conditions in Bosnia and Herzegovina (BiH) have remained stable. BiH has made progress in reducing internal and external imbalances in recent years, thanks to a prudent fiscal position, and a strong monetary anchor provided by the currency board. However, job creation has been limited, unemployment has remained high, particularly among the youth, and the income convergence with the European Union has stalled. Fiscal stability has been maintained, mainly through continued restraint on current government spending. Progress in improving budget composition has been limited and reforms of state enterprises have not progressed as envisaged.
Author: Siegel Donald S
Publisher: World Scientific
ISBN: 9813147040
Category : Business & Economics
Languages : en
Pages : 896
Get Book
Book Description
This multi-volume set covers a wide range of topics on innovation, which are all of great interest to academics, policymakers, university administrators, state and regional economic development officials, and students. Two unique features of the volume are the large body of global evidence on innovation presented and its consideration of the following timely and important topics in innovation: cybersecurity, open innovation, the globalization of R&D, and university technology transfer. Innovation is a topic of great importance in many fields in business administration, such as management, strategy, operations management, finance, marketing, and accounting, as well as in numerous social science disciplines, including economics, sociology, political science, and psychology. This volume fully reflects such interdisciplinary approaches.Volume 1 provides extensive global evidence on university technology transfer and innovation partnerships. Volume 2 is focused on the managerial and public policy implications of the globalization of R&D. Volume 3 presents state-of-the-art theoretical and empirical evidence on open innovation. Volume 4 is a comprehensive analysis of cybersecurity. This set is essential reading for those who wish to have a comprehensive understanding of the antecedents and consequences of innovation.
Author: Wangari Maathai
Publisher: Lantern Books
ISBN: 9781590560402
Category : Biography & Autobiography
Languages : en
Pages : 166
Get Book
Book Description
Wangari Maathai, founder of The Green Belt Movement, tells its story including the philosophy behind it, its challenges, and objectives.
